illumina

illumina
illumina logo

About

illumina is a biotechnology company that specializes in genetic sequencing and analysis. The company was founded in 1998 and is headquartered in San Diego, California. Illumina’s primary focus is on developing innovative technologies and solutions for genetic analysis that enable researchers to study complex biological systems and diseases in unprecedented detail.

Illumina’s flagship product is the sequencing platform, widely used in genomic research and clinical applications. The platform is based on a proprietary technology known as reversible terminator sequencing, which allows for highly accurate and efficient sequencing of DNA and RNA molecules. Illumina’s sequencing instruments can generate massive amounts of sequencing data in a short time, enabling researchers to sequence entire genomes, transcriptomes, and epigenomes at a fraction of the cost and time required by previous technologies.

illumina Medical Devices

1 – NovaSeq 6000 Series

The NovaSeq 6000 Series is a powerful and advanced sequencing system developed by Illumina. It is designed to offer scalable throughput and flexibility for a wide range of sequencing applications, from small to large-scale projects. Here are some key features of the NovaSeq 6000 Series:

NovaSeq 6000 Series

  • Scalable Throughput: The system can produce a tunable output of up to 6 terabases (Tb) and 20 billion single reads in less than 2 days, making it suitable for dynamic study sizes.
  • Broad and Deep Sequencing: It provides comprehensive coverage for whole-genome sequencing, whole-exome sequencing, and whole-transcriptome sequencing, allowing for impactful discoveries across various research areas.
  • Flexible Configurations: Users can mix and match flow cell types and run one or two flow cells at a time, with multiple read lengths and workflows available.
  • Streamlined Operations: The system features automated flow cell loading and is powered by XLEAP-SBS chemistry, which is known for its speed, quality, and robustness.
  • Integrated Analysis: The NovaSeq 6000 Series supports onboard or cloud-based DRAGEN analysis for efficient data processing.

The system’s specifications include a wide output range from 80 to 6000 gigabases (Gb), paired-end reads per run ranging from 1.6 billion to 40 billion, and a maximum read length of 2 × 250 base pairs (bp). The run time can vary from 13 to 44 hours depending on the configuration.

2 – MiSeq Dx System

MiSeq Dx System is a next-generation sequencing (NGS) platform designed for clinical diagnostic applications. It is capable of generating high-quality, accurate, and reliable sequencing data, making it an ideal choice for a wide range of clinical applications, such as infectious disease diagnosis, cancer profiling, and genetic testing. It uses Illumina’s proprietary sequencing-by-synthesis (SBS) technology, which enables it to sequence millions of DNA molecules in parallel.

MiSeq Dx System

One of the key features of the MiSeq Dx System is its flexibility. It can handle a variety of sample types, including DNA, RNA, and microbial samples. It can also accommodate different sequencing applications, such as whole-genome sequencing, targeted sequencing, and metagenomic sequencing. This makes it a versatile tool for a range of clinical applications.

3 – VeriSeq NIPT

VeriSeq NIPT (Non-Invasive Prenatal Testing) Solution is a high-throughput sequencing technology designed to detect fetal chromosomal abnormalities using a maternal blood sample. This solution uses Next-Generation Sequencing (NGS) technology to analyze cell-free DNA (cfDNA) from the maternal bloodstream to detect and quantify the relative amounts of chromosomal material from the fetus.

VeriSeq NIPT Solution

VeriSeq NIPT Solution can detect the most common chromosomal abnormalities, including trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). It can also detect sex chromosome aneuploidies, such as Turner syndrome (monosomy X) and Klinefelter syndrome (XXY).

The VeriSeq NIPT Solution is a comprehensive and accurate solution that can detect fetal chromosomal abnormalities with a high degree of sensitivity and specificity. It uses a unique molecular barcoding approach that reduces the risk of sequencing errors and allows for the accurate detection of fetal chromosomal abnormalities.

Medical Device Lists

Facebook
Twitter
LinkedIn
*All Fields Required
By sending a message, I agree with the Terms & Conditions and Privacy Policy.
This field is for validation purposes and should be left unchanged.

“Educate yourself. Be Prepared. Avoid Stress”.

Patient9 helps you choose which medical device is best for you.

Welcome to Patient9 medical device review – recommended website for patients. With specific information and tools created for patients and caregivers, you can get educated, reduce stress, and learn what to expect.

Related Medical Device Reviews

Neuralink Brain Implant Medical Device

Neuralink Corporation

About Neuralink Corporation is an American neurotechnology company founded by Elon Musk and others in 2016. The company’s primary focus is on developing and refining

Read More »
Allergan

Allergan

About Allergan is a global pharmaceutical company that specializes in developing and manufacturing prescription drugs and medical devices. The company was founded in 1950 and

Read More »
Dexcom

Dexcom

About Dexcom is a medical technology company that was founded in 1999 by a team of individuals including Scott Glenn, John Burd, Lauren Otsuki, Ellen

Read More »

Scroll to Top